Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients

Tissue Antigens

Volumn 82, Issue 2, 2013, Pages 83-92

  Susal C ^a   Roelen, D L ^b   Fischer, G ^c   Campos, E F ^d   Gerbase Delima, M ^d   Honger G ^e   Schaub, S ^e   Lachmann, N ^f   Martorell, J ^g   Claas, F ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Department of Immunohematology and Blood Transfusion ^*  (Netherlands)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d AFIP   (Brazil)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g Barcelona Clinic   (Spain)

Author keywords

Antibody screening; HLA antibodies; Kidney transplantation; Unacceptable HLA antigen mismatches; Virtual crossmatch

Indexed keywords

ALLOANTIBODY; HLA ANTIGEN;

COMPLEMENT DEPENDENT CYTOTOXICITY; GENETIC ALGORITHM; GENETIC PARAMETERS; GRAFT RECIPIENT; HLA TYPING; HUMAN; IMMUNOASSAY; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SOLID PHASE ANTIBODY DETECTION ASSAYS; UNACCEPTABLE HLA ANTIGEN MISMATCH; VIRTUAL REALITY;

ANTIBODY SCREENING; HLA ANTIBODIES; KIDNEY TRANSPLANTATION; UNACCEPTABLE HLA ANTIGEN MISMATCHES; VIRTUAL CROSSMATCH;

ALGORITHMS; DECISION TREES; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY; KIDNEY TRANSPLANTATION; UNRELATED DONORS;

EID: 84880384381     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12137     Document Type: Review

References (40)

1. Gebel HM, Bray RA, Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 2003: 3: 1488-500.
2. De Meester J, Persijn GG, Wujciak T, Opelz G, Vanrenterghem Y. The new Eurotransplant Kidney Allocation System: report one year after implementation. Eurotransplant International Foundation. Transplantation 1998: 66: 1154-9.
3. Claas FHJ, DE Waal LP, Beelen J et al. Transplantation of highly sensitized patients on basis of acceptable HLA-A and -B mismatches. Clin Transpl 1989: 185-90.
4. Claas FHJ, Rahmel A, Doxiadis IIN. Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. Transplantation 2009: 88: 447-52.
5. Fuggle SV, Martin S. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation 2008: 86: 384-90.
6. Foundation E. Eurotransplant Manual. Leiden: Eurotransplant Foundation, 2013. http://www.eurotransplant.org/cms/index.php?page=et_manual.
7. Lobo PI, Spencer CE, Stevenson WC, McCullough C, Pruett TL. The use of pronase-digested human leukocytes to improve specificity of the flow cytometric crossmatch. Transpl Int 1995: 8: 472-80.
8. Böhmig GA, Wahrmann M, Bartel G. Transplantation of the broadly sensitized patient: what are the options? Curr Opin Organ Transplant 2011: 16: 588-93.
9. Amico P, Hönger G, Mayr M, Steiger J, Hopfer H, Schaub S. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009: 87: 1681-8.
10. Taylor CJ, Kosmoliaptsis V, Sharples LD et al. Ten-year experience of selective omission of the pretransplant crossmatch test in deceased donor kidney transplantation. Transplantation 2010: 89: 185-93.
11. Medina-Pestana JO, Galante NZ, Tedesco-Silva H Jr et al. Kidney transplantation in Brazil and its geographic disparity. J Bras Nefrol 2011: 33: 472-84.
12. Tedesco-Silva H, Felipe CR, Abbud-Filho M, Garcia V, Medina-Pestana JO. The emerging role of Brazil in clinical trial conduct for transplantation. Am J Transplant 2011: 11: 1368-75.
13. Campos EF, Doxiadis I, Temin J et al. Proposal for a program to enhance renal transplantation opportunity for highly sensitized patients. J Bras Transplantes 2010: 13: 1251-5.
14. th International Congress of the Transplantation Society, Berlin 2012, MON-CO16.05.
15. Gloor JM, Winters JL, Cornell LD et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant 2010: 10: 582-9.
16. Bielmann D, Hönger G, Lutz D, Mihatsch MJ, Steiger J, Schaub S. Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant 2007: 7: 626-32.
17. Bächler K, Amico P, Hönger G et al. Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low-level donor-specific HLA-antibodies. Am J Transplant 2010: 10: 1254-62.
18. Amico P, Hirt-Minkowski P, Hönger G et al. Risk stratification by the virtual crossmatch: a prospective study in 233 renal transplantations. Transpl Int 2011: 24: 560-9.
19. Vlad G, Ho EK, Vasilescu ER et al. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Hum Immunol 2009: 70: 589-94.
20. Wahrmann M, Bartel G, Exner M et al. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients. Transpl Int 2009: 22: 982-9.
21. Lefaucheur C, Loupy A, Hill GS et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010: 21: 1398-406.
22. Willicombe M, Roufosse C, Brookes P et al. Antibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome. Transplantation 2011: 92: 176-82.
23. Caro-Oleas JL, González-Escribano MF, González-Roncero FM et al. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. Nephrol Dial Transplant 2012: 27: 1231-8.
24. Otten HG, Verhaar MC, Borst HP, Hené RJ, van Zuilen AD. Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure. Am J Transplant 2012: 12: 1618-23.
25. Huber L, Lachmann N, Dürr M et al. Identification and therapeutic management of highly sensitized patients undergoing renal transplantation. Drugs 2012: 72: 1335-54.
26. Dunn TB, Noreen H, Gillingham K et al. Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant 2011: 11: 2132-43.
27. Morales-Buenrostro LE, Terasaki PI, Marino-Vázquez LA, Lee J, El-Awar N, Alberú J. "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008: 86: 1111-5.
28. Cai J, Terasaki PI, Anderson N, Lachmann N, Schönemann C. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure. Transplantation 2009: 88: 226-30.
29. Mytilineos J, Deufel A, Opelz G. Clinical relevance of HLA-DPB locus matching for cadaver kidney retransplants: a report of the Collaborative Transplant Study. Transplantation 1997: 63: 1351-4.
30. Goral S, Prak EL, Kearns J et al. Preformed donor-directed anti-HLA-DP antibodies may be an impediment to successful kidney transplantation. Nephrol Dial Transplant 2008: 23: 390-2.
31. Gilbert M, Paul S, Perrat G et al. Impact of pretransplant human leukocyte antigen-C and -DP antibodies on kidney graft outcome. Transplant Proc 2011: 43: 3412-4.
32. Lee PC, Ozawa M, Hung CJ, Lin YJ, Chang SS, Chou TC. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Transplant Proc 2009: 41: 95-8.
33. van den Berg-Loonen EM, Billen EV, Voorter CE et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008: 85: 1086-90.
34. Süsal C, Ovens J, Mahmoud K et al. No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report. Transplantation 2011: 91: 883-7.
35. Roelen DL, Doxiadis II, Claas FH. Detection and clinical relevance of donor specific HLA antibodies: a matter of debate. Transpl Int 2012: 25: 604-10.
36. Pereira S, Perkins S, Lee JH et al. Donor-specific antibody against denatured HLA-A1: clinically nonsignificant? Hum Immunol 2011: 72: 492-8.
37. Poli F, Benazzi E, Innocente A et al. Heart transplantation with donor-specific antibodies directed toward denatured HLA-A*02:01: a case report. Hum Immunol 2011: 72: 1045-8.
38. Tait BD, Süsal C, Gebel HM et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2013: 95: 19-47.
39. Süsal C, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 2002: 73: 1269-73.
40. Montgomery RA, Lonze BE, King KE et al. Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 2011: 365: 318-26.